REPL vs SGEN
Replimune Group Inc (REPL) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
SGEN (SGEN) common stock.
REPL does not have a complete income-statement cache yet.
SGEN does not have a complete income-statement cache yet.
REPL currently screens at market cap $825.7M.
Not investment advice. Open the REPL and SGEN stock pages for the full models.
Not investment advice.